++
Chapter 1: Introduction
++
++
++
Which of the following describes the undesirable effects of chemicals on living systems?
++
++
++
++
++
++
++
++
++
++
++
++
Which of the following is a chemical that is synthesized by a plant or animal and is also detrimental to biologic processes?
++
++
++
++
++
++
++
++
++
++
++
++
Which of the following federal agencies oversees drug evaluation and marketing in the United States?
++
++
++
a. Drug Enforcement Agency (DEA)
++
++
b. National Institutes of Health (NIH)
++
++
c. United States Department of Agriculture (USDA)
++
++
d. Food and Drug Administration (FDA)
++
++
++
Which of the following must be filed prior to clinical human studies?
++
++
++
a. New Drug Application (NDA)
++
++
b. Investigation Exemption for a New Drug (IND)
++
++
c. Label of Research (LOR)
++
++
d. Program Project Grant (PPG)
++
++
++
The process of applying for marketing approval for a new drug is an NDA.
++
++
++
++
++
++
++
++
What is the maximum lifetime of a patent on a drug in the United States?
++
++
++
++
++
++
++
++
++
++
++
++
Which clinical research phase involves the largest number of human research subjects and is double blinded?
++
++
++
++
++
++
++
++
++
++
++
++
Once a drug receives an NDA, the manufacturer is not required to continue monitor the drug for safety.
++
++
++
++
++
++
++
++